comparemela.com
Home
Live Updates
Retrospective Analysis Shows Post-HCT Survival Benefits With Orca-T Vs PTCy in Hematologic Malignancies : comparemela.com
Retrospective Analysis Shows Post-HCT Survival Benefits With Orca-T Vs PTCy in Hematologic Malignancies
In a retrospective analysis, Orca-T improved survival rates vs PTCy in patients with hematologic malignancies receiving myeloablative conditioning.
Related Keywords
New York
,
United States
,
Alexandra Gomez Arteaga
,
Division Of Hematology
,
International Blood Marrow Transplant Research
,
Cellular Therapy
,
Gomez Arteaga
,
Medical Oncology
,
Weill Cornell
,
New York Presbyterian Hospital
,
During Orca T
,
International Blood
,
Marrow Transplant Research
,
Fasct
,
Transplant
,
Lymphoma
,
Transplantation Amp Cellular Therapy Meetings
,
Emtct
,
Orca T
,
Ptcy
,
Hematologic Malignancies
,
Myeloablative Conditioning
,
comparemela.com © 2020. All Rights Reserved.